| 1 |
35461077 | Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections. | 2022 May |
1 |
| 2 |
35588280 | Multiple Novel Ceftazidime-Avibactam-Resistant Variants of blaKPC-2-Positive Klebsiella pneumoniae in Two Patients. | 2022 May 19 |
3 |
| 3 |
34935416 | Comparison of Four Carbapenemase Detection Methods for blaKPC-2 Variants. | 2021 Dec 22 |
1 |
| 4 |
30617091 | Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa. | 2019 Apr |
1 |
| 5 |
29191131 | Efficacy of ceftazidime-avibactam in a rat intra-abdominal abscess model against a ceftazidime- and meropenem-resistant isolate of Klebsiella pneumoniae carrying blaKPC-2. | 2018 Apr |
1 |
| 6 |
29263067 | Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates. | 2018 Mar |
1 |
| 7 |
27221329 | The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria. | 2016 Aug |
1 |